Gathering collateral information while protecting privacy requires balancing the need for a complete clinical picture with patient confidentiality. Collateral information comes from people who know the patient well—family, friends, caregivers, teachers, or other professionals—and helps fill in gaps when the patient cannot fully report due to cognitive or communication limitations or when there are safety concerns that require a clearer assessment. You should obtain collateral information when the patient’s ability to report is limited or when safety risks exist. This ensures you have enough context to assess risks, clarify diagnoses, and plan appropriate treatment. Always seek the patient’s consent to share information when possible, and involve a legally authorized representative if the patient cannot provide informed consent. Protect privacy by sharing only what is necessary, using secure methods, and following data-sharing policies and privacy laws. Document what information was shared, with whom, for what purpose, and the consent status. This approach avoids relying on collateral information inappropriately, respects the patient’s rights, and recognizes that consent and privacy protections are integral to clinical decision-making. It’s not about obtaining collateral data only at the start, never sharing information, or requiring a court order every time—consent and privacy safeguards guide when and how this information is collected and shared.

The test hinges on how generalized anxiety disorder is distinguished from ordinary worry: the duration, breadth, and the impact on functioning. Generalized anxiety disorder involves excessive worry that occurs most days for at least six months, across a range of topics, and it’s hard to control the worry. It also comes with distress or impairment and often physical or cognitive symptoms like restlessness, fatigue, trouble concentrating, irritability, muscle tension, or sleep trouble. This combination—long-lasting, pervasive worry that disrupts life—is what sets GAD apart from normal worry, which tends to be brief, tied to a specific stressor, and not associated with substantial impairment. The other options don’t fit because normal worry isn’t limited to daily tasks, GAD isn’t about worrying only a single event, and a duration under six months wouldn’t meet the diagnostic threshold.

Low potassium in someone with anorexia nervosa signals a medical emergency because it directly risks life-threatening cardiac and muscular complications. A potassium level of 2.8 mEq/L is far below normal and can cause arrhythmias, muscle weakness, and other serious problems if not addressed promptly. This is why urgent notification to the clinician for immediate potassium repletion and close monitoring is essential. In contrast, the sodium value is normal, the WBC is within expected limits, and while a high HbA1c suggests poor long-term glucose control, it does not pose an immediate acute risk in the context of acute care for anorexia nervosa. The key concern for urgent action is the severe hypokalemia and the arrhythmia risk it creates.

Opening up the conversation to the client’s own view of why others are concerned is the key here. The best response invites the client to reflect on why the family sees anger as an issue, which helps you understand the meaning the client assigns to those concerns, how anger affects relationships, and any safety considerations. This builds rapport, reduces defensiveness, and gathers essential context for planning help with anger management and potential safety steps. Telling the client about changes to make jumps ahead to solutions without understanding the family’s perspective. Simply validating the family’s feelings acknowledges them but SAMPLEdoesn’t elicit the client’s side of the story. Asking whether the medication helps focuses on treatment without addressing the relational and safety dynamics at play.